CHEMO PHARMA LABORATORIES LTD.

Company Profile

CHEMO PHARMA LABORATORIES LTD. had its IPO on under the ticker symbol CHEMOPH.

The company operates in the sector and industry. CHEMO PHARMA LABORATORIES LTD. has a staff strength of 0 employees.

Stock update

Shares of CHEMO PHARMA LABORATORIES LTD. opened at ₹33.05 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹31.35 - ₹34, and closed at ₹31.35.

This is a -5% slip from the previous day's closing price.

A total volume of 100 shares were traded at the close of the day’s session.

In the last one week, shares of CHEMO PHARMA LABORATORIES LTD. have slipped by -14.6%.

CHEMO PHARMA LABORATORIES LTD.'s Key Ratios

CHEMO PHARMA LABORATORIES LTD. has a market cap of ₹54.75 million, indicating a price to book ratio of 0.5437 and a price to sales ratio of 0.

In the last 12-months CHEMO PHARMA LABORATORIES LTD.’s revenue was ₹0 with a gross profit of ₹9.95 million and an EBITDA of ₹0. The EBITDA ratio measures CHEMO PHARMA LABORATORIES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CHEMO PHARMA LABORATORIES LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, CHEMO PHARMA LABORATORIES LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

CHEMO PHARMA LABORATORIES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

20.2104

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CHEMO PHARMA LABORATORIES LTD.’s profitability.

CHEMO PHARMA LABORATORIES LTD. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 1.8389. Its price to sales ratio in the trailing 12-months stood at 0.

CHEMO PHARMA LABORATORIES LTD. stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹116.22 million

Total Liabilities

₹200000.00

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

CHEMO PHARMA LABORATORIES LTD. ended 2024 with ₹116.22 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹116.22 million while shareholder equity stood at ₹116.02 million.

CHEMO PHARMA LABORATORIES LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹200000.00 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹5.56 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

CHEMO PHARMA LABORATORIES LTD.’s total current assets stands at ₹61.29 million while long-term investments were ₹0 and short-term investments were ₹55.02 million. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 2024, CHEMO PHARMA LABORATORIES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, CHEMO PHARMA LABORATORIES LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹31.35

52-Week High

₹49.1

52-Week Low

₹27.17

Analyst Target Price

₹

CHEMO PHARMA LABORATORIES LTD. stock is currently trading at ₹31.35 per share. It touched a 52-week high of ₹49.1 and a 52-week low of ₹49.1. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹33.72 and 200-day moving average was ₹36.98 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.